Prostate Cancer - Results from #160

Live Cell Molecular Analysis of Primary Prostate Cancer Organoids Identifies Persistent Androgen Receptor Signaling - Beyond the Abstract January 14, 2022

A High-Risk Decipher Biopsy Score is Associated with Conversion from Active Surveillance to Treatment and Treatment Failure in Localized Prostate Cancer - Beyond the Abstract January 5, 2022

Health-Related Quality of Life in Men with Localized Prostate Cancer Treated with Radiotherapy: Validation of an Abbreviated Version of the Expanded Prostate Cancer Index Composite for Clinical Practice in Spain - Beyond the Abstract January 5, 2022

Detection Rate of 18F-Choline Positron Emission Tomography/Computed Tomography in Patients with Non-Metastatic Hormone Sensitive and Castrate Resistant Prostate Cancer - Beyond the Abstract January 3, 2022

Prostate MRI Improves Diagnostic Performance of PSA for High Grade Prostate Cancer - Beyond the Abstract January 3, 2022

A Comparative Study of Anticoagulant/Antiplatelet Therapy Among Men Undergoing Robot-Assisted Radical Prostatectomy: A Prospective Single Institution Study - Beyond the Abstract December 15, 2021

HIFU in Radio-Recurrent Localized Prostate Cancer - Beyond the Abstract December 14, 2021

Disparities in Germline Testing Among Racial Minorities with Prostate Cancer: Bridging Disparities in Germline Testing Among Men with Prostate Cancer - Beyond the Abstract December 7, 2021

Exploring the Impact of Treatment Switching on Overall Survival from the PROfound Study in Homologous Recombination Repair (HRR)-Mutated Metastatic Castration-Resistant Prostate Cancer (mCRPC) - Beyond the Abstract December 6, 2021

Reliability of Serial Prostate Magnetic Resonance Imaging to Detect Prostate Cancer Progression During Active Surveillance: A Systematic Review and Meta-analysis - Beyond the Abstract December 6, 2021

Popularized: Discovered Gene Patterns Can Predict Prostate Cancer Treatment Response - Beyond the Abstract November 16, 2021

Avelumab Combined with Stereotactic Ablative Body Radiotherapy in Metastatic Castration-Resistant Prostate Cancer: The Phase 2 ICE-PAC Clinical Trial - Beyond the Abstract November 2, 2021

Efficacy and Safety of Cabazitaxel Versus Abiraterone or Enzalutamide in Older Patients With Metastatic Castration-Resistant Prostate Cancer in the CARD Study – Beyond the Abstract October 25, 2021

Prostate-Specific Antigen Testing as Part of a Risk-Adapted Early Detection Strategy for Prostate Cancer: European Association of Urology Position and Recommendations for 2021 - Beyond the Abstract October 25, 2021

Early Detection of Prostate Cancer in 2020 and Beyond: Facts and Recommendations for the European Union and the European Commission. - Beyond the Abstract October 20, 2021

A European Model for an Organised Risk-stratified Early Detection Programme for Prostate Cancer - Beyond the Abstract October 20, 2021

A Machine Learning Approach to Predict Progression on Active Surveillance for Prostate Cancer - Beyond the Abstract September 28, 2021

Comparative Analysis of 1152 African-American and European-American Men with Prostate Cancer Identifies Distinct Genomic and Immunological Differences - Beyond the Abstract September 14, 2021

Association of Age with Risk of Adverse Pathological Findings in Men Undergoing Delayed Radical Prostatectomy Following Active Surveillance - Beyond the Abstract September 9, 2021

Real-World Safety and Effectiveness of Radium-223 in Japanese Patients with Castration-Resistant Prostate Cancer (CRPC) and Bone Metastasis - Beyond the Abstract September 2, 2021

Page 9 of 51